Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

EZWeightLossTX LLC: Atomic and XPLODE Weight Loss Supplements Recalled for Drug Contamination

Agency Publication Date: December 20, 2017
Share:
Sign in to monitor this recall

Summary

EZWeightLossTX LLC is recalling 4,958 bottles of LaBri's Body Health Atomic (60 capsules) and 1,424 bottles of LaBri's Body Health XPLODE (30 capsules) because they were found to contain sibutramine. These products were marketed as dietary supplements but are actually unapproved drugs due to the presence of the undeclared medication. Consumers who purchased these products should immediately stop using them and contact a healthcare provider or pharmacist for guidance, as sibutramine was previously removed from the market for safety reasons.

Risk

The product contains sibutramine, an undeclared drug ingredient that can significantly increase blood pressure and pulse rate. This poses a serious safety risk to consumers with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke, and may interact in life-threatening ways with other medications.

What You Should Do

  1. Identify if you have 'LaBri's Body Health Atomic' (60 capsules) or 'LaBri's Body Health XPLODE' (30 capsules) by checking the product label.
  2. Check the lot information on your bottle; this recall includes all lots currently remaining within their expiration dates.
  3. Immediately stop using these capsules to avoid health risks from the undeclared drug sibutramine.
  4. Contact your healthcare provider or pharmacist for guidance regarding any health concerns or to discuss alternative weight loss treatments.
  5. Return any unused product to the place of purchase for a refund and contact EZWeightLossTX LLC for further instructions.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Return product to place of purchase

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: LaBri's Body Health Atomic (60 Capsules)
Model:
D-0121-2018
Lot Numbers:
All lots remaining within expiry
Product: LaBri's Body Health XPLODE (30 capsules)
Model:
D-0122-2018
Lot Numbers:
All lots remaining within expiry

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 77817
Status: Resolved
Manufacturer: EZWeightLossTX LLC
Sold By: LaBri's Body Health
Manufactured In: United States
Units Affected: 2 products (4958 bottles; 1424 bottles)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.